J. Goldman & Co LP - ACER THERAPEUTICS INC ownership

ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 31 filers reported holding ACER THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of ACER THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$943,000
+219.7%
360,000
+389.7%
0.05%
+128.6%
Q4 2019$295,000
-39.4%
73,510
-51.9%
0.02%
-43.2%
Q3 2019$487,000
+24.9%
152,800
+52.8%
0.04%
+37.0%
Q2 2019$390,000
-55.6%
100,001
+145.8%
0.03%
-40.0%
Q2 2018$879,000
-49.4%
40,684
-54.9%
0.04%
-39.2%
Q1 2018$1,738,000
+16.2%
90,202
-16.5%
0.07%
-6.3%
Q4 2017$1,496,000108,0000.08%
Other shareholders
ACER THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Worth Venture Partners, LLC 250,518$722,0000.59%
Nantahala Capital Management 990,655$2,853,0000.09%
GSA CAPITAL PARTNERS LLP 82,421$237,0000.04%
FEDERATED HERMES, INC. 117,673$339,0000.00%
BNP PARIBAS FINANCIAL MARKETS 179$516,0000.00%
Horan Securities, Inc. 24$00.00%
OSAIC HOLDINGS, INC. 200$1,0000.00%
BANK OF AMERICA CORP /DE/ 3$00.00%
WELLS FARGO & COMPANY/MN 29$00.00%
NORTHERN TRUST CORP 31,083$90,0000.00%
View complete list of ACER THERAPEUTICS INC shareholders